NewVale Capital is a growth equity firm investing in proven life science services and enabling technologies for healthcare.
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 10.09.2025 | Noxilizer | noxilizer.com | $30M | United Sta... |
Mentions in press and media 4
| Date | Title | Description |
| 02.07.2026 | CAI Closes Recapitalization with JLL Partners, Unlocking New Opportunities for Growth | New partnership positions CAI to accelerate its global expansion, technology investment and enhanced service offerings INDIANAPOLIS, July 2, 2026 /PRNewswire/ -- CAI, a professional services firm dedicated to accelerating operational readin... |
| 10.09.2025 | Noxilizer Raises $30M in Funding | Noxilizer, a Hanover, MD-based company which specializes in nitrogen dioxide-based terminal sterilization for biopharmaceutical and medical device products, raised $30M in funding. The round was led by NewVale Capital. The company intends t... |
| 13.05.2024 | NewVale Capital wraps up debut fund at $167m | - |
| 13.05.2024 | Business | Boulder-based NewVale Capital closes first fund with $167M to invest in life-sciences space | - |